reducing cardiovascular risk: an emphasis on rosuvastatin

reducing cardiovascular risk: an emphasis on rosuvastatin

;Anikin G.S.;Storozhuk I.K.;Filyazova Ya.Yu.
pediatric urology case reports 2017 Vol. 14 pp. 50-54
188
g.s.2017reducing

Abstract

Rosuvastatin is one of the most frequently prescribed drugs for primary and secondary prevention of myocardial infarction and stroke. The present article deals with the main studies confirming the effectiveness of rosuvastatin in patients with different cardiovascular risks.

Citation

ID: 200220
Ref Key: g.s.2017reducing
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
200220
Unique Identifier:
10.26442/2075-082X_14.4.50-54
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet